Sessioni Comunicazioni Orali


Pharmacogenetics, pharmacogenomics and gene therapy

Saturday, October 28th / 9.00-11.00
113THE PREDICTIVE VALUE OF ABCB1, ABCG2, CYP3A4/5, AND CYP2D6 POLYMORPHISMS FOR RISPERIDONE AND ARIPIPRAZOLE PLASMA CONCENTRATIONS AND THE OCCURRENCE OF ADVERSE DRUG REACTIONS
Bernardi FF., Vitale A., Sessa M., Mascolo A., Scavone C., Maccariello A., Rafaniello C., Rossi F., Capuano A.
114CLOPIDOGREL PHARMACOGENETICS: A VALID METHOD TO ASSURE EFFECTIVENESS AND APPROPRIATENESS OF THE ANTIPLATELET THERAPY
Conti V., Manzo V., Sellitto C., Iannaccone T., Costantino M., Corbi G., Malangone P., Tarallo S., Iannello F., Nicolella G., Accarino G., Filippelli A.
115COMPARISON OF FOUR DIFFERENT ASSAY METHODS FOR UGT1A1*28 GENOTYPING
Costanza F., Mancini I., Salvianti F., Gelmini S., Tassi R., Mazzei T., Nobili S., Mini E., Pazzagli M., Pinzani P., Simi L.
116PHARMACOGENETICS OF SOFOSBUVIR , A NEW ANTI-HCV DRUG: A PRELIMINARY STUDY.
Cusato J., De nicolo' A., Boglione L., Ariaudo A., Favata F., Mornese pinna S., Carcieri C., Di perri G., D'avolio A.
117TACKLE ATHEROSCLEROSIS VIA GENOME EDITING: CRISPR MEETS ApoA-I MILANO
Pizzino G., Mannino F., Irrera N., Pallio G., Galfo F., Mecchio A., Minutoli L., Squadrito F., Altavilla D., Bitto A.
118PREPARE (PRE-EMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS), A PHARMACOGENOMIC RANDOMIZED CLINICAL TRIAL WITHIN THE U-PGX H2020 PROGRAM, TO DRIVE PHARMACOGENOMICS INTO CLINICAL PRACTICE IN 7 EUROPEAN CLINICAL ENVIRONMENTS, TO IMPROVE PATIENTS SAFETY AND QUALITY OF LIFE- THE ITALIAN EXPERIENCE
Bignucolo A., Roncato R., Di raimo T., De mattia E., D'andrea M., Giordano G., Foltran L., Berretta M., De paoli A., Guardascione M., Lo re G., Buonadonna A., Saracchini S., Favaretto A., Sandri P., Toffoli G.
119A TRANSCRIPTOMIC PROFILE PREDICTS CLINICAL OUTCOME IN STAGE III COLORECTAL CANCER PATIENTS TREATED WITH ADJUVANT CHEMOTHERAPY
Nobili S., D'aurizio R., Perrone G., Magi A., Lapucci A., Tassi R., Napoli C., Picariello L., Landini I., Brugia M., Mazzei T., Tonelli F., Mini E.
121Immunogenetics of prostate cancer: first clinical insights
Dreussi E., Zanusso C., Gagno S., De mattia E., Romanato L., Sartor F., Bortolus R., Romualdi C., Quartuccio L., Cecchin E., Toffoli G.
335Identification and validation of ADME polymorphic variants correlated to taxane neurotoxicity and survival in breast cancer patients by DMET microarray platform
Arbitrio M., Viscomi C., Di Martino MT., Botta C., Galeano T., Staropoli N., Iuliano E., Scionti F., Altomare E., Iannone M., Vecchio I., Strongoli MC., Agapito G., Cannataro M., Tassone P., Tagliaferri P.